News Brexit could deny children access to cancer drug trials Experts call for shake-up of EU regulation.
News Tax breaks could nurture UK’s cell and gene therapy manufact... Tax breaks for R&D and innovative manufacturing could be part of life sciences strategy.
News NHS set to lose out to Brexit in budget Brexit bill and debt levels make spending spree unlikely, says Chancellor
News Lords defy government with post-Brexit guarantee for EU nati... Peers introduce amendment to Brexit bill.
News Thousands of doctors could quit UK because of Brexit Four in ten EEA doctors considering quitting, says survey.
News Norgine rejoins ABPI after eight year absence ABPI says Norgine's support will be important during Brexit.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
